284 related articles for article (PubMed ID: 23518714)
41. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity.
Latouche M; Fragner P; Martin E; El Hachimi KH; Zander C; Sittler A; Ruberg M; Brice A; Stevanin G
Mol Cell Neurosci; 2006 Mar; 31(3):438-45. PubMed ID: 16325416
[TBL] [Abstract][Full Text] [Related]
42. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
[TBL] [Abstract][Full Text] [Related]
43. Decreased expression of Hsp27 and Hsp70 in transformed lymphoblastoid cells from patients with spinocerebellar ataxia type 7.
Tsai HF; Lin SJ; Li C; Hsieh M
Biochem Biophys Res Commun; 2005 Sep; 334(4):1279-86. PubMed ID: 16039988
[TBL] [Abstract][Full Text] [Related]
44. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.
Huynh DP; Figueroa K; Hoang N; Pulst SM
Nat Genet; 2000 Sep; 26(1):44-50. PubMed ID: 10973246
[TBL] [Abstract][Full Text] [Related]
45. A role for both wild-type and expanded ataxin-7 in transcriptional regulation.
Ström AL; Forsgren L; Holmberg M
Neurobiol Dis; 2005 Dec; 20(3):646-55. PubMed ID: 15936949
[TBL] [Abstract][Full Text] [Related]
46. A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
Sánchez I; Piñol P; Corral-Juan M; Pandolfo M; Matilla-Dueñas A
Hum Mol Genet; 2013 Sep; 22(17):3425-37. PubMed ID: 23630944
[TBL] [Abstract][Full Text] [Related]
47. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
La Spada AR; Fu YH; Sopher BL; Libby RT; Wang X; Li LY; Einum DD; Huang J; Possin DE; Smith AC; Martinez RA; Koszdin KL; Treuting PM; Ware CB; Hurley JB; Ptácek LJ; Chen S
Neuron; 2001 Sep; 31(6):913-27. PubMed ID: 11580893
[TBL] [Abstract][Full Text] [Related]
48. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
[TBL] [Abstract][Full Text] [Related]
49. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.
Niu C; Prakash TP; Kim A; Quach JL; Huryn LA; Yang Y; Lopez E; Jazayeri A; Hung G; Sopher BL; Brooks BP; Swayze EE; Bennett CF; La Spada AR
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381411
[TBL] [Abstract][Full Text] [Related]
50. Spinocerebellar ataxia 7 (SCA7).
Lebre AS; Brice A
Cytogenet Genome Res; 2003; 100(1-4):154-63. PubMed ID: 14526176
[TBL] [Abstract][Full Text] [Related]
51. A novel central nervous system-enriched spinocerebellar ataxia type 7 gene product.
Einum DD; Clark AM; Townsend JJ; Ptacek LJ; Fu YH
Arch Neurol; 2003 Jan; 60(1):97-103. PubMed ID: 12533095
[TBL] [Abstract][Full Text] [Related]
52. Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
Niewiadomska-Cimicka A; Trottier Y
Neurotherapeutics; 2019 Oct; 16(4):1074-1096. PubMed ID: 31432449
[TBL] [Abstract][Full Text] [Related]
53. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8.
Moseley ML; Zu T; Ikeda Y; Gao W; Mosemiller AK; Daughters RS; Chen G; Weatherspoon MR; Clark HB; Ebner TJ; Day JW; Ranum LP
Nat Genet; 2006 Jul; 38(7):758-69. PubMed ID: 16804541
[TBL] [Abstract][Full Text] [Related]
54. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
Watase K; Gatchel JR; Sun Y; Emamian E; Atkinson R; Richman R; Mizusawa H; Orr HT; Shaw C; Zoghbi HY
PLoS Med; 2007 May; 4(5):e182. PubMed ID: 17535104
[TBL] [Abstract][Full Text] [Related]
55. Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats.
Ansorge O; Giunti P; Michalik A; Van Broeckhoven C; Harding B; Wood N; Scaravilli F
Ann Neurol; 2004 Sep; 56(3):448-52. PubMed ID: 15349877
[TBL] [Abstract][Full Text] [Related]
56. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
Xia H; Mao Q; Eliason SL; Harper SQ; Martins IH; Orr HT; Paulson HL; Yang L; Kotin RM; Davidson BL
Nat Med; 2004 Aug; 10(8):816-20. PubMed ID: 15235598
[TBL] [Abstract][Full Text] [Related]
57. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
Garden GA; La Spada AR
Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
[TBL] [Abstract][Full Text] [Related]
58. The linker histone H1C contributes to the SCA7 nuclear phenotype.
Kizilyaprak C; Spehner D; Devys D; Schultz P
Nucleus; 2011; 2(5):444-54. PubMed ID: 21970987
[TBL] [Abstract][Full Text] [Related]
59. Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.
Martin J; Van Regemorter N; Del-Favero J; Löfgren A; Van Broeckhoven C
J Neurol Sci; 1999 Sep; 168(1):37-46. PubMed ID: 10500272
[TBL] [Abstract][Full Text] [Related]
60. Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice.
Iizuka A; Nakamura K; Hirai H
Neurosci Lett; 2015 Apr; 592():37-41. PubMed ID: 25725171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
